Skip to main content

'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles

Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.